Evolus Inc (STU:EVL)
€ 5.22 -0.28 (-5.13%) Market Cap: 344.66 Mil Enterprise Value: 445.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Q2 2025 Evolus Inc Earnings Call Transcript

Aug 05, 2025 / 08:30PM GMT
Release Date Price: €7.6 (-1.94%)
Operator

Good afternoon everyone and thank you for standing by. Welcome to Evolus second quarter earnings conference call. (Operator Instructions)

I would now like to turn the conference over to Nareg Sagherian, Vice President and Head of Global Investor Relations and Corporate Communications. Please go ahead.

Nareg Sagherian
Evolus Inc - Vice President and Head of Global Investor Relations and Corporate Communications

Thank you, operator, and welcome to everyone joining us on today's call to review Evolus' second quarter financial results. Our second quarter press release is now on our website at evolus.com. With me today are David Moatazedi, President and Chief Executive Officer; and Rui Avelar, Chief Medical Officer and Head of R&D.

Today's call will include forward-looking statements. Actual results may differ materially due to risks and uncertainties outlined in our earnings press release and SEC filings. These forward-looking statements are based on current assumptions, and we undertake no obligation to update them.

Additionally,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot